{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:20:30Z","timestamp":1792783230758,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Institutional Fluid Research grant, Christian Medical College Vellore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11102-025-01556-7","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T19:22:19Z","timestamp":1753298539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dopamine receptor expression predicts cabergoline response in persistent somatotroph adenoma"],"prefix":"10.1007","volume":"28","author":[{"given":"Remya","family":"Rajan R.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesarghatta","family":"Shyamasunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjayan","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjani","family":"Jeyachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari G.","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Prabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Rajaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"1556_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.clineuro.2014.09.004","volume":"126","author":"S Sarkar","year":"2014","unstructured":"Sarkar S, Rajaratnam S, Chacko G, Chacko AG (2014) Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly. Clin Neurol Neurosurg 126:190\u2013195","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"1556_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1530\/eje.1.01863","volume":"152","author":"P Nomikos","year":"2005","unstructured":"Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u2018cure\u2019. Eur J Endocrinol 152(3):379\u2013387","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1556_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","volume":"24","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L et al (2021) A pituitary society update to acromegaly management guidelines. Pituitary 24(1):1\u201313","journal-title":"Pituitary"},{"issue":"7","key":"1556_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.4158\/EP-2018-0040","volume":"24","author":"DM Donegan","year":"2018","unstructured":"Donegan DM, I\u00f1iguez-Ariza N, Sharma A, Nippoldt T, Young W, Van Gompel J et al (2018) Necessity of multimodal treatment of acromegaly and outcomes. Endocr Pract 24(7):668\u2013676","journal-title":"Endocr Pract"},{"issue":"9","key":"1556_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH et al (2018) A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14(9):552\u2013561","journal-title":"Nat Rev Endocrinol"},{"key":"1556_CR6","doi-asserted-by":"crossref","unstructured":"Urwyler SA, Samperi I, Lithgow K, Mavilakandy A, Matheou M, Bradley K et al (2024) Efficacy of Cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study. Eur J Endocrinol. 2024;190(1):113\u201320","DOI":"10.1093\/ejendo\/lvae003"},{"issue":"3","key":"1556_CR7","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/jcmm.13440","volume":"22","author":"E Venegas-Moreno","year":"2018","unstructured":"Venegas-Moreno E, Vazquez-Borrego MC, Dios E, Gros-Herguido N, Flores-Martinez A, Rivero-Cort\u00e9s E et al (2018) Association between dopamine and somatostatin receptor expression and Pharmacological response to somatostatin analogues in acromegaly. J Cell Mol Med 22(3):1640\u20131649","journal-title":"J Cell Mol Med"},{"issue":"4","key":"1556_CR8","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1210\/jc.2007-1358","volume":"93","author":"D Ferone","year":"2008","unstructured":"Ferone D, de Herder WW, Pivonello R, Kros JM, van Koetsveld PM, de Jong T et al (2008) Correlation of in vitro and in vivo somatotropic adenoma responsiveness to somatostatin analogs and dopamine agonists with immunohistochemical evaluation of somatostatin and dopamine receptors and electron microscopy. J Clin Endocrinol Metab 93(4):1412\u20131417","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1556_CR9","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1556_CR10","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metabolism 95(7):3141\u20133148","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"1556_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C et al (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7\u201322","journal-title":"Pituitary"},{"key":"1556_CR12","doi-asserted-by":"crossref","unstructured":"Gomez-hernandez K, Ezzat S, Asa SL, Mete O (2015) Clinical implications of accurate subtyping of pituitary adenomas: perspectives from the treating physician. TJPATH. [cited 2023 Aug 18]; Available from: http:\/\/www.turkjpath.org\/doi.php?doi=10.5146\/tjpath.2015.01311","DOI":"10.5146\/tjpath.2015.01311"},{"issue":"4","key":"1556_CR13","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1210\/jcem.85.4.6547","volume":"85","author":"D Ferone","year":"2000","unstructured":"Ferone D, van Hagen MP, Kwekkeboom DJ, van Koetsveld PM, Mooy DM, Lichtenauer-Kaligis E et al (2000) Somatostatin receptor subtypes in human thymoma and Inhibition of cell proliferation by octreotide in vitro. J Clin Endocrinol Metabolism 85(4):1719\u20131726","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"5","key":"1556_CR14","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1210\/jc.2003-030837","volume":"89","author":"R Pivonello","year":"2004","unstructured":"Pivonello R, Ferone D, de Herder WW, Kros JM, Del Caro B, Arvigo ML (2004) Dopamine receptor expression and function in corticotroph pituitary tumors. J Clin Endocrinol Metabolism 89(5):2452\u20132462","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"11","key":"1556_CR15","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/modpathol.3800954","volume":"20","author":"M Volante","year":"2007","unstructured":"Volante M, Brizzi MP, Faggiano A, La Rosa S, Rapa I, Ferrero A et al (2007) Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 20(11):1172\u20131182","journal-title":"Mod Pathol"},{"issue":"1","key":"1556_CR16","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.1210\/jc.2012-2609","volume":"98","author":"F Gatto","year":"2013","unstructured":"Gatto F, Feelders RA, van der Pas R, Kros JM, Waaijers M, Sprij-Mooij D et al (2013) Immunoreactivity score using an Anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly. J Clin Endocrinol Metabolism 98(1):E66\u201371","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"4","key":"1556_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"key":"1556_CR18","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1016\/j.wneu.2021.05.030","volume":"151","author":"A Goyal-Honavar","year":"2021","unstructured":"Goyal-Honavar A, Sarkar S, Asha HS, Kapoor N, Thomas R, Balakrishnan R et al (2021) Impact of experience on outcomes after endoscopic transsphenoidal surgery for acromegaly. World Neurosurg 151:e1007\u2013e1015","journal-title":"World Neurosurg"},{"issue":"1","key":"1556_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s42000-021-00327-w","volume":"21","author":"L Rass","year":"2022","unstructured":"Rass L, Rahvar AH, Matschke J, Saeger W, Renn\u00e9 T, Aberle J et al (2022) Differences in somatostatin receptor subtype expression in patients with acromegaly: new directions for targeted therapy? Hormones 21(1):79\u201389","journal-title":"Hormones"},{"key":"1556_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mce.2015.09.016","volume":"417","author":"K Kiseljak-Vassiliades","year":"2015","unstructured":"Kiseljak-Vassiliades K, Xu M, Mills TS, Smith EE, Silveira LJ, Lillehei KO et al (2015) Differential somatostatin receptor (SSTR) 1\u20135 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors. Mol Cell Endocrinol 417:73\u201383","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"1556_CR21","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1210\/jc.2010-2443","volume":"96","author":"L Sandret","year":"2011","unstructured":"Sandret L, Maison P, Chanson P (2011) Place of Cabergoline in acromegaly: a meta-analysis. J Clin Endocrinol Metab 96(5):1327\u20131335","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1556_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1210\/jcem.83.2.4556","volume":"83","author":"R Abs","year":"1998","unstructured":"Abs R, Verhelst J, Maiter D, Van Acker K, Nobels F, Coolens JL et al (1998) Cabergoline in the treatment of acromegaly: a study in 64 patients. J Clin Endocrinol Metab 83(2):374\u2013378","journal-title":"J Clin Endocrinol Metab"},{"key":"1556_CR23","doi-asserted-by":"crossref","unstructured":"Iacovazzo D, Carlsen E, Lugli F, Chiloiro S, Piacentini S, Bianchi A et al (2015) Factors predicting Pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. Eur J Endocrinol\/Eur Fed Endocr Soc. 174","DOI":"10.1530\/EJE-15-0832"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01556-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-025-01556-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01556-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:56:40Z","timestamp":1757275000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-025-01556-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1556"],"URL":"https:\/\/doi.org\/10.1007\/s11102-025-01556-7","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"7 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}